These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23094125)

  • 1. Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Kim YS; Kim HJ; Lee JW; Kim BG; Bae DS; Huh SJ; Nam JH
    J Gynecol Oncol; 2012 Oct; 23(4):226-34. PubMed ID: 23094125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy.
    Jang TK; Shin SJ; Chung H; Kwon SH; Cha SD; Lee E; Shin C; Cho CH
    Obstet Gynecol Sci; 2017 Nov; 60(6):549-557. PubMed ID: 29184863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
    Zivanovic O; Alektiar KM; Sonoda Y; Zhou Q; Iasonos A; Tew WP; Diaz JP; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2008 Nov; 111(2):265-70. PubMed ID: 18774596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
    Liu P; Lin L; Kong Y; Huo Z; Zhu L; Bin X; Lang J; Chen C
    BMC Cancer; 2020 Mar; 20(1):189. PubMed ID: 32138718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
    Akhavan S; Alibakhshi A; Parsapoor M; Alipour A; Rezayof E
    BMC Cancer; 2021 Jun; 21(1):667. PubMed ID: 34088300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary radical hysterectomy vs chemoradiation for IB2-IIA cervical cancer: A systematic review and meta-analysis.
    Yan RN; Zeng Z; Liu F; Zeng YY; He T; Xiang ZZ; Zhang BL; Gong HL; Liu L
    Medicine (Baltimore); 2020 Jan; 99(5):e18738. PubMed ID: 32000377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma.
    Darus CJ; Callahan MB; Nguyen QN; Pastore LM; Schneider BF; Rice LW; Jazaeri AA
    Int J Gynecol Cancer; 2008; 18(4):730-5. PubMed ID: 17949426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of radical surgery in women with stage IB2/IIA2 cervical cancer.
    Derks M; Biewenga P; van der Velden J; Kenter GG; Stalpers LJ; Buist MR
    Acta Obstet Gynecol Scand; 2016 Feb; 95(2):166-72. PubMed ID: 26575692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
    Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
    Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
    Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH
    Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of Hysterectomy Following Chemoradiation for IB2/IIA2 Cervical Cancer in the National Cancer Data Base.
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2018 May; 38(5):3175-3179. PubMed ID: 29715159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.
    Albert A; Allbright R; Lee A; Vijayakumar S
    J Gynecol Oncol; 2019 May; 30(3):e41. PubMed ID: 30887759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Single-Institution Radical Surgery Results in Stage IB2/IIA2 (Bulky) Cervical Cancer.
    Khatib G; Küçükgöz Güleç Ü; Bariş Güzel A; Uygur B; Seydaoğlu G; Gümürdülü D; Vardar MA
    Int J Gynecol Cancer; 2016 Oct; 26(8):1480-4. PubMed ID: 27465899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.